AACAP. Clinical Use of Pharmacogenetic Tests in Prescribing Psychotropic Medications for Children and Adolescents. Washington DC; 2020. Available from: https://www.aacap.org/AACAP/Policy_Statements/Home.aspx [Last accessed: December27, 2023].
2.
BousmanCA, StevensonJM, RamseyLB, et al.Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther, 2023; 114(1):51–68; doi: 10.1002/cpt.2903
3.
De LeonJ, SusceMT, Murray-CarmichaelE. The AmpliChip™ CYP450 genotyping test: Integrating a new clinical tool. Mol Diagnosis Ther, 2006; 10(3); doi: 10.1007/BF03256453
4.
NamerowLB, RamseyLB, MalikS, et al.Editorial: Beyond red light, green light: Examining the role of pharmacogenomics in evidence-based care in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry, 2022; 61(1); doi: 10.1016/j.jaac.2021.11.001
5.
RamseyLB, NamerowLB, BishopJR, et al.Thoughtful clinical use of pharmacogenetics in child and adolescent psychopharmacology. J Am Acad Child Adolesc Psychiatry, 2020; 0(0); doi: 10.1016/j.jaac.2020.08.006
6.
RosenblatJD, LeeY, McIntyreRS. The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis. J Affect Disord, 2018; 241(April):484–491; doi: 10.1016/j.jad.2018.08.056
7.
Vande VoortJL, OrthSS, ShekunovJ, et al.A randomized controlled trial of combinatorial pharmacogenetics testing in adolescent depression. J Am Acad Child Adolesc Psychiatry, 2022; 61(1):46–55.
8.
ZeierZ, CarpenterLL, KalinNH, et al.Clinical implementation of pharmacogenetic decision support tools for antidepressant drug prescribing. Am J Psychiatry, 2018; 175(9); doi: 10.1176/appi.ajp.2018.17111282
